Not Signed In -
Osteoporosis |
Bone Loss |
Clinical Trial: Comparison of Osteoporosis Disease Management Strategies
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to assess the impact of disease management interventions on bone mineral density screening rates and osteoporosis treatment rates in women age 50-64 years at high risk for osteoporosis.
| Condition | Intervention |
|---|---|
| Osteoporosis | Behavior: Disease Management Assessment |
MedlinePlus related topics: Osteoporosis
Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Open Label, Placebo Control, Parallel Assignment
Official Title: Evaluation of Strategies for Increasing Osteoporosis Screening and Treatment in a Managed Care Organization
Further Study Details:
Primary Outcomes: Bone mineral density screening rates
Secondary Outcomes: Medications adoptions; Medications adherence
Expected Total Enrollment: 4685
Secondary Outcomes: Medications adoptions; Medications adherence
Expected Total Enrollment: 4685
Study start: July 2004
Eligibility
Ages Eligible for Study: 50 Years - 64 Years, Genders Eligible for Study: Female
Criteria
Inclusion Criteria:
- Members of the Harvard Pilgrim Health Plan
Exclusion Criteria:
- Individuals who are not members of the Harvard Pilgrim Health Plan
Location Information
Study chairs or principal investigators
Medical Monitor, Study Director, Merck
More Information
Study ID Numbers: 2005_050
Last Updated: September 7, 2005
Record first received: September 1, 2005
ClinicalTrials.gov Identifier: NCT00145080
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: September 7, 2005
Record first received: September 1, 2005
ClinicalTrials.gov Identifier: NCT00145080
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-13
email this page
print this page
bookmark this page
feedback on this page
